CLDX - Celldex Therapeutics, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 42.56

Open

$ 41.94

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 41.42 - $ 42.85

52 Week Range

$ 22.11 - $ 53.18

Volume

605,345

Average Volume

Market Cap

2.06B

Beta (5Y Monthly)

$ 0.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-26-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-29-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-06-2020	03-31-2020	10-Q
17	03-26-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-07-2019	03-31-2019	10-Q
21	03-07-2019	12-31-2018	10-K
22	11-07-2018	09-30-2018	10-Q
23	08-08-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-07-2018	12-31-2017	10-K
26	11-07-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	03-14-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-08-2016	06-30-2016	10-Q
32	05-05-2016	03-31-2016	10-Q
33	02-23-2016	12-31-2015	10-K
34	11-05-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	04-29-2015	03-31-2015	10-Q
37	02-24-2015	12-31-2014	10-K
38	11-05-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-01-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Cell...
04/17/2024 14:35:54

HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $80 ...

Celldex Completes Enrollment In Phase 2 St...
04/17/2024 12:01:49

Cantor Fitzgerald Reiterates Overweight on...
03/22/2024 17:51:56

Cantor Fitzgerald analyst Kristen Kluska reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Overweight and maintains $67 p...

Market-Moving News for March 15th
03/15/2024 12:36:47

MDGL: 28% | Madrigal Pharmaceuticals shares are trading higher after the company announced FDA approval of Rezdiffra for the tr...

cooper-companies-reports-upbeat-results-joins-dell-netapp-tidewater-and-other-big-stocks-moving-higher-on-friday

Cooper Companies Reports Upbeat Results, J...
03/01/2024 16:18:21

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Reported Earlier, Celldex Therapeutics Pri...
03/01/2024 08:06:21

In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 1,278,000...

Celldex Therapeutics Proposes To Offer And...
02/28/2024 21:02:26

All of the shares of common stock are being offered by the Company.

Guggenheim Maintains Buy on Celldex Therap...
02/27/2024 17:04:44

Guggenheim analyst Yatin Suneja maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $72...

why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Freshpet Shares Are Trading Higher By ...
02/26/2024 18:57:55

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

Celldex Therapeutics: Q4 Earnings Insights
02/26/2024 16:55:05

Celldex Therapeutics Entered Deal To Sell ...
02/26/2024 14:58:29

- SEC Filing

Celldex Therapeutics Q4 EPS $(0.83) Misses...
02/26/2024 12:05:31

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate o...

Celldex Therapeutics Earlier Announced Pha...
02/24/2024 23:25:31

Primary and secondary endpoints met with clinically meaningful and statistically significant decreases in urticaria disease act...

Celldex Announces Upcoming Presentation Of...
02/05/2024 13:12:36

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing 12 week results from the Company's Pha...

Forecasting The Future: 5 Analyst Projecti...
12/20/2023 19:00:42

TD Cowen Initiates Coverage On Celldex The...
12/20/2023 13:34:20

TD Cowen analyst Yaron Werber initiates coverage on Celldex Therapeutics (NASDAQ:CLDX) with a Outperform rating.

top-4-health-care-stocks-that-may-crash-this-month

Top 4 Health Care Stocks That May Crash Th...
12/20/2023 13:31:40

As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

What 7 Analyst Ratings Have To Say About C...
11/10/2023 14:00:10

Wells Fargo Upgrades Celldex Therapeutics ...
11/10/2023 11:27:02

Wells Fargo analyst Derek Archila upgrades Celldex Therapeutics (NASDAQ:CLDX) from Underweight to Equal-Weight and announces...

why-celldex-therapeutics-cldx-stock-is-getting-hammered

Why Celldex Therapeutics (CLDX) Stock Is G...
11/08/2023 19:58:26

Celldex Therapeutics, Inc. (NASDAQ: CLDX) shares are trading lower after the company announced a proposed public offering of 7....